Address: 3F, No.465, Sec.6, Zhongxiao E. Rd., Taipei 11557, Taiwan. R.O.C
Tel: 886-2-8170-6000
Web: http://www2.cde.org.tw/Pages/default.aspx
Company description
The Center for Drug Evaluation (CDE) was established by the Department of Health (DOH) of Taiwan on July 13, 1998 as a non-government, non-profit organization. CDE evaluates new drugs and new medical devices and provides health technology assessment for regulatory requirements commissioned by DOH. Related consultation services are offered. Furthermore, CDE develops pharmaceutical regulatory science and makes timely recommendations to meet the need of policy development. With the vision – Regulatory Science, Service for Life, CDE plays a pivotal role in enhancing the efficiency and quality of drug and device evaluation, thus promoting public health and welfare. CDE is committed to contribute to the national public health system and to ensure that the public can obtain safe, effective, and innovative drugs and devices in a timely manner.
Products and services
CDE evaluates new drugs and new medical devices for regulatory requirements and offers related consultation services under the delegation and commission of DOH. Furthermore, CDE develops pharmaceutical regulatory science and makes timely recommendations to meet the need of policy development. Thus, CDE contributes to the national public health system and ensures that the public can obtain safe and effective innovative new drugs in a timely manner through the efforts of a team of full-time professionals .